Organization Profile

You just read:

Oncolytics Biotech® Inc. Announces Start of Enrollment in Phase 1b Study of Multiple Myeloma Looking at REOLYSIN® in Combination with Bortezomib

News provided by

Oncolytics Biotech Inc.

Nov 18, 2015, 06:30 ET